01.11.2006
Prospective Antitumor Effects of the Combination of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) and Cisplatin Against Esophageal Squamous Cell Carcinoma
Erschienen in: Surgery Today | Ausgabe 11/2006
Einloggen, um Zugang zu erhalten